Neuronal expression of NOS-1 is required for host recovery from viral encephalitis

Virology

Volumn 258, Issue 2, 1999, Pages 389-395

  Komatsu, Takashi ^a   Ireland, Derek D C ^a   Chen, Nannan ^a   Reiss, Carol Shoshkes ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

Acquired immunity; Innate immunity; Interleukin 12; Nitric oxide synthase; Viral infection

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; NITRIC OXIDE SYNTHASE; RECOMBINANT INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CHO CELL; CONTROLLED STUDY; ENDOTHELIUM CELL; EPENDYMA CELL; HOST RESISTANCE; INTRAPERITONEAL DRUG ADMINISTRATION; KNOCKOUT MOUSE; MACROPHAGE; MALE; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VESICULAR STOMATITIS VIRUS; VIRUS ENCEPHALITIS; WEIGHT REDUCTION;

ANIMALIA; RNA VIRUSES; VESICULAR STOMATITIS VIRUS;

EID: 0033526524     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9734     Document Type: Article

References (50)

1. Adler H., Beland J. L., Del-Pan N. C., Kobzik L., Brewer J. P., Martin T. R., Rimm I. Suppression of herpes simplex type I (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS-2). J. Exp. Med. 185:1997;1533-1540.
2. Barna M., Komatsu T., Reiss C. S. Activation of type III nitric oxide synthase in astrocytes following a neurotropic viral infection. Virology. 223:1996;331-343.
3. Bi Z., Reiss C. S. Inhibition of vesicular stomatitis virus infection by nitric oxide. J. Virol. 69:1995;2208-2213.
4. Bi Z., Barna M., Komatsu T., Reiss C. S. Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity. J. Virol. 69:1995;6466-6471.
5. Bredt D. S., Snyder S. H. Nitric oxide: A physiological messenger molecule. Annu. Rev. Biochem. 63:1994;175-195.
6. Chan S. H., Perussia B., Gupta J. W., Kobayashi M., Pospisil M., Young H. A., Wolf S., Young D., Clark S. C., Trinchieri G. Induction of interferon-γ production by natural killer cell stimulatory factor: Characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:1991;869-879.
7. Chehimi A., Valiante N., D'Andrea A., Rengaraju M., Rosado Z., Kobayashi M., Perussia B., Wolf S. F., Starr S. E., Trinchieri G. Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells. Eur. J. Immunol. 23:1993;1826-1830.
8. Constantinescu C. S., Frei K., Malipiero U., Rostami A., Fontana A. Astrocytes and microglial produce IL-12. Ann. N.Y. Acad. Sci. 795:1996;323-333.
9. Coutelier J. P., Broeck J. V., Wolf S. F. Interleukin-12 gene expression after viral infection in the mouse. J. Virol. 69:1995;1955-1958.
10. Dawson T. M., Dawson V. L. Nitric oxide: Actions and pathological roles. Neuroscientists. 1:1994;9-20.
11. Dawson V. L., Dawson T. M., London E. D., Bredt D. S., Snyder S. H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA. 88:1991;6368.
12. Forger J. M., Bronson R. T., Huang A. S., Reiss C. S. Murine Infection by vesicular stomatitis virus: Initial characterization of the H-2d system. J. Virol. 65:1991;4950-4958.
13. Furchgott R. F., Zawadzki J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373-376.
14. Galea E., Reis D. J., Feinstein D. C. Cloning and expression of inducible nitric oxide synthase from rat astrocytes. J. Neurosci. Res. 37:1994;406-414.
15. Harris N., Mark R., Buller L., Karupiah G. Gamma interferon-induced nitric oxide-mediated inhibition of vaccinia virus replication. J. Virol. 69:1995;910-915.
16. Huang P. L., Dawson T. M., Bredt D. S., Snyder S. H., Fishman M. C. Targeted disruption of the neuronal nitric oxide synthase gene. Cell. 75:1993;1273-1286.
17. Huang Z., Huang P. L., Panahian N., Dalkara T., Fishman M. C., Moskowitz M. A. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 265:1994;1883-1885.
18. Huneycutt B. S., Bi Z., Aoki C. J., Reiss C. S. Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice. J. Virol. 67:1993;6698-6706.
19. Ireland D. C. D., Bang T., Komatsu T., Reiss C. S. Delayed administration of IL-12 is efficacious in promoting recovery from lethal viral encephalitis. Viral Immunol. 12:1999;35-40.
20. Kamijo R., Harada H., Matsuyama T., Bosland M., Gerecitano J., Shapiro D., Le J., Koh S. I., Kimura Y., Green S. J., Mak T. W., Taniguchi T., Vilcek J. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science. 263:1994;1612-1615.
21. Karupiah G., Xie Q. W., Buller R. M. L., Nathan C., Duarte C., Macmicking J. D. Inhibition of viral replication by interferon-γ induced nitric oxide synthase. Science. 261:1993;1445-1448.
22. Karupiah G., Harris N. Inhibition of viral replication by nitric oxide and its reversal by ferrous sulfate and tricarboxylic acid cycle metabolites. J. Exp. Med. 181:1995;2171-2179.
23. Kobayashi M., Fitz L., Ryan M., Hewick R. M., Clark S. C., Chan S., Loudon R., Sherman F., Perussia B., Trinchieri G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:1989;827-846.
24. Komatsu T., Bi Z., Reiss C. S. IFN-γ induced Type I nitric oxide synthase activity inhibits viral replication in neurons. J. Neuroimmunol. 68:1996;101-108.
25. Komatsu, T, Ireland, D. D. C, Chung, N, Dore, A, Yoder, M, and, Reiss, C. S. 1999a. Regulation of the BBB during viral encephalitis: Roles of IL-12 and NOS. [submitted for publication].
26. Komatsu T., Ireland D. D. C., Reiss C. S. IL-12 and viral infections. Cytokines Growth Factor Rev. 9:1998;277-285.
27. Komatsu T., Reiss C. S. IFN-γ is not required in the IL-12 response to vesicular stomatitis virus infection of the olfactory bulb. J. Immun. 159:1997;3444-3452.
28. Komatsu T., Srivastava N., Revzin M., Ireland D. D. C., Chesler D., Reiss C. S. Mechanisms of NO inhibition of viral replication. Virology. 1999b.
29. Koprowski H., Zheng Y. M., Heber-Katz E., Fraser N., Rorke L., Fu Z. F., Hanlon C., Dietschold B. In vivo expression of inducible nitric oxide synthase in experimentally induced neurological diseases. Proc. Natl. Acad. Sci. USA. 90:1993;3024-3027.
30. Lee S. C., Dickson D. W., Brosnan C. F., Casadevall A. Human astrocytes inhibit Cryptococcus neoformans growth by a nitric-oxide mediated mechanism. J. Exp. Med. 180:1994;365-369.
31. Lin Y.-L., Huang Y.-L., Ma S.-H., Yeh C.-T., Chiou S.-Y., Chen L.-K., Liao C.-L. Inhibition of Japanese encephalitis virus infection by nitric oxide: Antiviral effect of NO on RNA virus replication. J. Virol. 71:1997;5227-5235.
32. Manetti R., Parronchi P., Giudizi M. G., Piccinni M. P., Maggi E., Trinchieri G., Romagnani S. Natural killer stimulatory factor (interleukin 12) induces T helper type-1 (Th1)-specific immune responses and inhibits the development of IL-4-producing cells. J. Exp. Med. 177:1993;1199-1204.
33. Marletta M. A. Nitric oxide synthase: Aspects concerning structure and catalysis. Cell. 78:1994;927-930.
34. Merill J. E., Ignarro L. J., Sherman M. P., Melinek J., Lane T. E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151:1993;2132-2141.
35. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
36. Nathan C., Xie Q. W. Nitric oxide synthase: Roles, tolls, and controls. Cell. 78:1994;915-918.
37. Palmer R. M., Ferrige A. G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
38. Plakhov I. V., Aoki C., Arlund E. G., Reiss C. S. The earliest events in VSV infection of the murine olfactory neuroepithelium and entry of the central nervous system. Virology. 209:1995;257-262.
39. Reiling N., Ulmer A. J., Duchow M., Ernst M., Flad H.-D., Hauschildt S. Nitric oxide synthase in RNA expression of different isoforms in human monocytes/macrophages. Eur. J. Immunol. 24:1994;1941-1944.
40. Reiss C. S., Komatsu T. Minireview: Does nitric oxide play a critical rolloe in viral infections. J. Virol. 72:1998;4547-4551.
41. Saura M., Zaragoza C., McMillan A., Quick R. A., Hohenadi C., Lowenstein J. M., Lowenstein C. J. An antiviral mechanism of nitric oxide: Inhibition of a viral protease. Immunity. 10:1999;21-28.
42. Schmidt H. H. H. W., Walter U. NO at work. Cell. 78:1994;919-925.
43. Schoenhaut D. S., Chua A. O., Wolitzky A. G., Guinn P. M., Dwyer C. M., McComas W., Familletti P. C., Gately M. K., Gubler U. Cloning and expression of murine IL-12. J. Immunol. 148:1992;3433-3440.
44. + T Cells. J. Exp. Med. 180:1994;353-358.
45. Stadler A. K., Pagenstecher A., Yu N. C., Kincaid C., Chiang C. S., Hobbs M. V., Bloom F. E., Campbell I. L. Lipopolysaccharide-induced IL-12 expression in the central nervous system and cultured astrocytes and microglia. J. Immunol. 159:1997;1344-1351.
46. Stenger S., Thuring H., Rollinghoff M., Bogdan C. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania Major. J. Exp. Med. 180:1994;783-793.
47. Wolf S. F., Temple P. A., Kobayashi M., Young D., Dicig M., Lowe L., Dizialo R., Fritz L., Ferenz C., Hewick R. M., Kelleher K., Herrmann S. H., Clark S. C., Azzoni L., Chan S. H., Trincheiri G., Perussia B. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biological effects on T and natural killer cells. J. Exp. Med. 146:1991;3074-3081.
48. Wolf S. F., Sieburth D., Sypek J. Interleukin-12: A key modulator of immune functions. Stem Cell. 12:1994;154-168.
49. Xie J., Roddy P., Rife T. K., Murad F., Young A. P. Two closely linked but separable promoters for human neuronal nitric oxide synthase gene transcription. Proc. Natl. Acad. Sci. USA. 92:1995;1242.
50. Zielasek J., Tausch M., Toyka K. V., Hartung H. P. Production of nitrite by neonatal rat microglial cells/brain macrophages. Cell. Immunol. 141:1992;111-120.